As previously reported, the reduction of inflammation may be related to weight loss, that was significant in the different outcome trials, going from a 0.6-kg reduction at 12 weeks with Lixisenatide in ELIXA trial to 4.3 kg at 2 years with injectable semaglutide in SUSTAIN-6 trial [25, 26]
"The first step for a patient to consider is to confirm whether it is a plan exclusion or whether prior authorization is required, says Dr
Ethics declarations Competing interests F.B
Shima Hadidchi MD Family Practice is proud to offer Semaglutide GLP-1, a once-weekly injection that helps reduce blood sugar levels and supports weight loss
Although early research shows promise, it remains largely experimental, and long-term safety data is still limited
Cushman, MD, professor of physical medicine and rehabilitation at the University of Utah Health